229 related articles for article (PubMed ID: 23835888)
1. CPT: Pharmacometrics and Systems Pharmacology.
van der Graaf PH
CPT Pharmacometrics Syst Pharmacol; 2012 Sep; 1(9):e8. PubMed ID: 23835888
[TBL] [Abstract][Full Text] [Related]
2. Open access: a new model for publishing in the pharmacological sciences.
Conway M
CPT Pharmacometrics Syst Pharmacol; 2012 Sep; 1(9):e7. PubMed ID: 23835887
[TBL] [Abstract][Full Text] [Related]
3. Advancing pharmacometrics and systems pharmacology.
Waldman SA; Terzic A
Clin Pharmacol Ther; 2012 Nov; 92(5):535-7. PubMed ID: 23085873
[TBL] [Abstract][Full Text] [Related]
4. Has the time come for predictive computer modeling in CNS drug discovery and development?
Geerts H; Spiros A; Roberts P; Carr R
CPT Pharmacometrics Syst Pharmacol; 2012 Nov; 1(11):e16. PubMed ID: 23835798
[TBL] [Abstract][Full Text] [Related]
5. Pharmacometrics and Systems Pharmacology Software Tutorials and Use: Comments and Guidelines for PSP Contributions.
Vicini P; Friberg LE; van der Graaf PH; Rostami-Hodjegan A
CPT Pharmacometrics Syst Pharmacol; 2013 Dec; 2(12):e86. PubMed ID: 24352522
[TBL] [Abstract][Full Text] [Related]
6. Basic concepts in population modeling, simulation, and model-based drug development.
Mould DR; Upton RN
CPT Pharmacometrics Syst Pharmacol; 2012 Sep; 1(9):e6. PubMed ID: 23835886
[TBL] [Abstract][Full Text] [Related]
7. Pharmacometrics and Systems Pharmacology 2030.
Mentré F; Friberg LE; Duffull S; French J; Lauffenburger DA; Li L; Mager DE; Sinha V; Sobie E; Zhao P
Clin Pharmacol Ther; 2020 Jan; 107(1):76-78. PubMed ID: 31758700
[TBL] [Abstract][Full Text] [Related]
8. Modeling and simulation in clinical pharmacology and dose finding.
Staab A; Rook E; Maliepaard M; Aarons L; Benson C
CPT Pharmacometrics Syst Pharmacol; 2013 Feb; 2(2):e29. PubMed ID: 23835940
[TBL] [Abstract][Full Text] [Related]
9. Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose.
Keizer RJ; Karlsson MO; Hooker A
CPT Pharmacometrics Syst Pharmacol; 2013 Jun; 2(6):e50. PubMed ID: 23836189
[TBL] [Abstract][Full Text] [Related]
10. Drug and disease model resources: a consortium to create standards and tools to enhance model-based drug development.
Harnisch L; Matthews I; Chard J; Karlsson MO
CPT Pharmacometrics Syst Pharmacol; 2013 Mar; 2(3):e34. PubMed ID: 23887647
[TBL] [Abstract][Full Text] [Related]
11. Application of ggplot2 to Pharmacometric Graphics.
Ito K; Murphy D
CPT Pharmacometrics Syst Pharmacol; 2013 Oct; 2(10):e79. PubMed ID: 24132163
[TBL] [Abstract][Full Text] [Related]
12. The Role of Modeling and Simulation in Development and Registration of Medicinal Products: Output From the EFPIA/EMA Modeling and Simulation Workshop.
Manolis E; Rohou S; Hemmings R; Salmonson T; Karlsson M; Milligan PA
CPT Pharmacometrics Syst Pharmacol; 2013 Feb; 2(2):e31. PubMed ID: 23835942
[TBL] [Abstract][Full Text] [Related]
13. Modeling and simulation as a tool to bridge efficacy and safety data in special populations.
Harnisch L; Shepard T; Pons G; Della Pasqua O
CPT Pharmacometrics Syst Pharmacol; 2013 Feb; 2(2):e28. PubMed ID: 23835939
[TBL] [Abstract][Full Text] [Related]
14. Opinion: the pharmacometrics of infectious disease.
Davies GR; Hope W; Khoo S
CPT Pharmacometrics Syst Pharmacol; 2013 Aug; 2(8):e70. PubMed ID: 23985968
[TBL] [Abstract][Full Text] [Related]
15. The impact of mathematical modeling on the understanding of diabetes and related complications.
Ajmera I; Swat M; Laibe C; Le Novère N; Chelliah V
CPT Pharmacometrics Syst Pharmacol; 2013 Jul; 2(7):e54. PubMed ID: 23842097
[TBL] [Abstract][Full Text] [Related]
16. Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors.
Demin O; Karelina T; Svetlichniy D; Metelkin E; Speshilov G; Demin O; Fairman D; van der Graaf PH; Agoram BM
CPT Pharmacometrics Syst Pharmacol; 2013 Sep; 2(9):e74. PubMed ID: 24026253
[TBL] [Abstract][Full Text] [Related]
17. Sobol Sensitivity Analysis: A Tool to Guide the Development and Evaluation of Systems Pharmacology Models.
Zhang XY; Trame MN; Lesko LJ; Schmidt S
CPT Pharmacometrics Syst Pharmacol; 2015 Feb; 4(2):69-79. PubMed ID: 27548289
[TBL] [Abstract][Full Text] [Related]
18. Using network biology to bridge pharmacokinetics and pharmacodynamics in oncology.
Kirouac DC; Onsum MD
CPT Pharmacometrics Syst Pharmacol; 2013 Sep; 2(9):e71. PubMed ID: 24005988
[TBL] [Abstract][Full Text] [Related]
19. Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosis.
Riggs MM; Bennetts M; van der Graaf PH; Martin SW
CPT Pharmacometrics Syst Pharmacol; 2012 Oct; 1(10):e11. PubMed ID: 23887363
[TBL] [Abstract][Full Text] [Related]
20. White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulation.
Vlasakakis G; Comets E; Keunecke A; Gueorguieva I; Magni P; Terranova N; Della Pasqua O; de Lange EC; Kloft C
CPT Pharmacometrics Syst Pharmacol; 2013 May; 2(5):e40. PubMed ID: 23887723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
